Adisseo Deputy GM Wang Yan Fined by Liaoning Regulator Over Prior Employer Issue

Adisseo announced on the evening of September 4, 2026, that its deputy general manager Wang Yan had received an Administrative Penalty Decision from the Liaoning Securities Regulatory Bureau. The penalty stems from matters related to another company where Wang previously worked and does not involve Adisseo. The company stated that the matter will not have a material adverse impact on its daily production and operations.

As of the date of the announcement, Wang Yan has not been subject to any market-entry ban by the China Securities Regulatory Commission, nor has he been publicly identified by any stock exchange as unsuitable to serve as a director or senior executive of a listed company. The matter has not resulted in any disqualification under relevant rules.

Adisseo held the 16th meeting of its ninth board of directors on June 18, 2026, at which it approved the appointment of Wang Yan as deputy general manager. The company focuses on the research, development, production, and sale of animal nutrition and health additives, with products divided into two categories: functional products and specialty products.

In the first half of 2026, Adisseo achieved double-digit growth in both revenue and net profit, primarily driven by strong sales performance of methionine, which saw simultaneous increases in volume and price in the second quarter. All specialty product lines delivered robust business growth, helping the specialty segment maintain double-digit year-on-year growth in revenue and gross profit, which offset the adverse impact of rising raw material costs.